JPRN-UMIN000034459已完成未知
Validation Study of Pyrroloquinoline quinone disodium salt (PQQ 2Na) for Improvement of Brain Function in Healthy Adults - Validation Study of Pyrroloquinoline quinone disodium salt (PQQ 2Na) for Improvement of Brain Function in Healthy Adults
HUMA R&D CORP0 个研究点目标入组 70 人开始时间: 2020年5月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients suffering from serious liver and kidney disease, heart disease, respiratory disorders, endocrine disorders, diabetes mellitus, food allergy, drug allergy, cancer, dementia and psychiatric disorders 2)Patients allergic to gelatin 3)Patients who wish to be pregnant, lactating, or pregnant during the study period 4)Patients who have ingested PQQ 2Na within 3 months before the test 5)Patients who are deemed ineligible to participate in the study.
研究者
相似试验
已完成
不适用
Safety confirmation test of pyrroloquinoline quinone disodium salt-containing food/A (healthy adults)JPRN-UMIN000044411Oneness support Co., Ltd.23
已完成
不适用
Effectiveness of pyrroloquinone quinone amino acid on mental status of Japanese subjectsHealthy adultJPRN-UMIN000032270Kagawa Nutrition University50
进行中（未招募）
1 期
Pharmacokinetic evaluation of fluoroquinolone antibiotics administered intravenously in intensive care patients with normal renal function and with renal hyperfiltratioIntensive care patientsEUCTR2010-019691-70-BEGhent University
已完成
不适用
Efficacy of respiratory quinolones for the treatment of community acquired pneumonia: a randomized controlled trial of moxifloxacin versus garenoxacin.JPRN-UMIN000005515agasaki evaluation organization for clinical interventions120
已完成
3 期
The effect of quinolone-containing regimens for the treatment of Helicobacter pylori infection.Helicobacter pylori infection.Helicobacter pylori [H.pylori] as the cause of diseases classified to other chaptersIRCT2012101311101N1Shiraz University of Medical Sciences140